{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:15Z","timestamp":1791209295868,"version":"4.1.0"},"reference-count":60,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["NIH-DK128443"],"award-info":[{"award-number":["NIH-DK128443"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer anorexia\u2212cachexia syndrome (CACS) is a prevalent and debilitating complication of malignancy, characterized by reduced food intake, loss of skeletal muscle mass, and severe metabolic dysfunction. Insulin resistance and impaired glucose tolerance are prominent features of CACS and contribute to worsened prognosis, yet treatment options that improve metabolic regulation without exacerbating anorexia are limited. Although GLP-1 receptor (GLP-1R) agonists effectively enhance glucose control, their centrally mediated anorectic and aversive effects limit their use in cancer patients. To address this limitation, we developed a peripherally restricted GLP-1R agonist by conjugating exendin-4 (Ex4) to dicyanocobinamide (Cbi), a vitamin B12-derived corrin ring with minimal blood\u2212brain barrier penetration. Here, we evaluate Cbi-Ex4 in vitro and across healthy and tumor-bearing rodent models. Cbi-Ex4 retained GLP-1R agonism and improved glucose tolerance without inducing anorexia, weight loss, or malaise, in contrast to native Ex4. These findings support peripheralized GLP-1R agonism as a promising strategy to improve metabolic dysfunction in cancer without worsening malaise and cachexia.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00590","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:02:16Z","timestamp":1788764536000},"page":"4988-4997","source":"Crossref","is-referenced-by-count":0,"title":["A Dicyanocobinamide Conjugate of the GLP-1R Agonist Exendin-4 Improves Glucose Homeostasis in Tumor-Bearing Rats without Exacerbating Anorexia and Weight Loss"],"prefix":"10.1021","volume":"23","author":[{"given":"Nancy","family":"Cham","sequence":"first","affiliation":[{"name":"Syracuse University , , , ,","place":["Syracuse, New York, United States, 13244"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Pataro","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]},{"name":"University of Southern California , , , ,","place":["Los Angeles, California, United States, 90089"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Liles","sequence":"additional","affiliation":[{"name":"Syracuse University , , , ,","place":["Syracuse, New York, United States, 13244"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace K.","family":"Choi","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia L.","family":"Fischer","sequence":"additional","affiliation":[{"name":"University of Southern California , , , ,","place":["Los Angeles, California, United States, 90089"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Ramadan","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena X.","family":"Gao","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]},{"name":"University of Southern California , , , ,","place":["Los Angeles, California, United States, 90089"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Doebley","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg G.","family":"Chepurny","sequence":"additional","affiliation":[{"name":"Upstate Medical University , , , ,","place":["Syracuse, New York, United States, 13245"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1781-3580","authenticated-orcid":true,"given":"George G.","family":"Holz","sequence":"additional","affiliation":[{"name":"Upstate Medical University , , , ,","place":["Syracuse, New York, United States, 13245"]},{"name":"Upstate Medical University , , , ,","place":["Syracuse, New York, United States, 13245"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]},{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"De Jonghe","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]},{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-5656","authenticated-orcid":true,"given":"Robert P.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Syracuse University , , , ,","place":["Syracuse, New York, United States, 13244"]},{"name":"Upstate Medical University , , , ,","place":["Syracuse, New York, United States, 13245"]},{"name":"Upstate Medical University , , , ,","place":["Syracuse, New York, United States, 13245"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9438-695X","authenticated-orcid":true,"given":"Tito","family":"Borner","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]},{"name":"University of Southern California , , , ,","place":["Los Angeles, California, United States, 90089"]},{"name":"University of Pennsylvania , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026100509323808100_cit1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ncponc0112","article-title":"Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself","volume":"2","author":"Laviano","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"2026100509323808100_cit2","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/cmar.s261585","article-title":"Cancer Cachexia: Definition, Staging, and Emerging Treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manage. Res."},{"key":"2026100509323808100_cit3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"2026100509323808100_cit4","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2026100509323808100_cit5","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"2026100509323808100_cit6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argile\u0301s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"2026100509323808100_cit7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/1097-0142(195611\/12)9:6&lt;1127::aid-cncr2820090610&gt;3.0.co;2-4","article-title":"Diabetes and altered carbohydrate metabolism in patients with cancer","volume":"9","author":"Glicksman","year":"1956","journal-title":"Cancer"},{"key":"2026100509323808100_cit8","first-page":"3710","article-title":"Altered glucose metabolism in metastatic carcinoma","volume":"35","author":"Holroyde","year":"1975","journal-title":"Cancer Res."},{"key":"2026100509323808100_cit9","first-page":"4665","article-title":"Insulin resistance in patients with cancer","volume":"38","author":"Lundholm","year":"1978","journal-title":"Cancer Res."},{"key":"2026100509323808100_cit10","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/1097-0142(19841215)54:12&lt;3022::aid-cncr2820541234&gt;3.0.co;2-k","article-title":"Glucose intolerance in sarcoma patients","volume":"54","author":"Norton","year":"1984","journal-title":"Cancer"},{"key":"2026100509323808100_cit11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/07315724.1992.10718249","article-title":"A review of cancer cachexia and abnormal glucose metabolism in humans with cancer","volume":"11","author":"Tayek","year":"1992","journal-title":"J. Am. Coll. Nutr."},{"key":"2026100509323808100_cit12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026100509323808100_cit13","doi-asserted-by":"publisher","first-page":"a041530","DOI":"10.1101\/cshperspect.a041530","article-title":"Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus","volume":"13","author":"Dang","year":"2023","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"2026100509323808100_cit14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-024-00332-8","article-title":"Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia","volume":"12","author":"Ruan","year":"2024","journal-title":"Cancer Metab."},{"key":"2026100509323808100_cit15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/jco.2002.20.1.42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study","volume":"20","author":"Goodwin","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"2026100509323808100_cit16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10552-009-9492-y","article-title":"Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey","volume":"21","author":"Parekh","year":"2010","journal-title":"Cancer Causes Control."},{"key":"2026100509323808100_cit17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/bjc.1978.200","article-title":"Mechanism of impaired glucose tolerance in patients with neoplasia","volume":"38","author":"Jasani","year":"1978","journal-title":"Br. J. Cancer"},{"key":"2026100509323808100_cit18","doi-asserted-by":"publisher","first-page":"E1033","DOI":"10.1152\/ajpendo.1990.258.6.e1033","article-title":"Insulin secretion in Walker 256 tumor cachexia","volume":"258","author":"Fernandes","year":"1990","journal-title":"Am. J. Physiol."},{"key":"2026100509323808100_cit19","doi-asserted-by":"publisher","first-page":"C804","DOI":"10.1152\/ajpcell.1996.271.3.c804","article-title":"Impairment of insulin secretion in pancreatic islets isolated from Walker 256 tumor-bearing rats","volume":"271","author":"el Razi Neto","year":"1996","journal-title":"Am. J. Physiol."},{"key":"2026100509323808100_cit20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int. J. Cancer"},{"key":"2026100509323808100_cit21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"2026100509323808100_cit22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","article-title":"The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice","volume":"25","author":"Chambers","year":"2017","journal-title":"Cell Metab."},{"key":"2026100509323808100_cit23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1172\/jci42497","article-title":"Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice","volume":"122","author":"Lamont","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2026100509323808100_cit24","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/dom.14089","article-title":"A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models","volume":"22","author":"Borner","year":"2020","journal-title":"Diabetes, Obes. Metab."},{"key":"2026100509323808100_cit25","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"2026100509323808100_cit26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu1589","article-title":"Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models","volume":"11","author":"Borner","year":"2025","journal-title":"Sci. Adv."},{"key":"2026100509323808100_cit27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/nejmoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026100509323808100_cit28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/erc-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"2026100509323808100_cit29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"Ca-Cancer J. Clin."},{"key":"2026100509323808100_cit30","doi-asserted-by":"publisher","first-page":"107768","DOI":"10.1016\/j.celrep.2020.107768","article-title":"Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Rep."},{"key":"2026100509323808100_cit31","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1021\/acs.jmedchem.1c00185","article-title":"Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4","volume":"64","author":"Tinsley","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026100509323808100_cit32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/bph.15647","article-title":"Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?","volume":"179","author":"Borner","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026100509323808100_cit33","doi-asserted-by":"publisher","first-page":"7752","DOI":"10.1021\/jo501364b","article-title":"Microwave-Assisted Cobinamide Synthesis","volume":"79","author":"o\u0301 Proinsias","year":"2014","journal-title":"J. Org. Chem."},{"key":"2026100509323808100_cit34","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.3641","article-title":"FRET Reporter Assays for cAMP and Calcium in a 96-well Format Using Genetically Encoded Biosensors Expressed in Living Cells","volume":"10","author":"Milliken","year":"2020","journal-title":"Bio-Protoc."},{"key":"2026100509323808100_cit35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0031-9384(76)90171-2","article-title":"Poison induced pica in rats","volume":"17","author":"Mitchell","year":"1976","journal-title":"Physiol. Behav."},{"key":"2026100509323808100_cit36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0091-3057(93)90126-e","article-title":"Pica in rats is analogous to emesis: an animal model in emesis research","volume":"45","author":"Takeda","year":"1993","journal-title":"Pharmacol., Biochem. Behav."},{"key":"2026100509323808100_cit37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jcsm.12169","article-title":"Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1\/GDF15","volume":"8","author":"Borner","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026100509323808100_cit38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","article-title":"Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat","volume":"131","author":"Borner","year":"2018","journal-title":"Neuropharmacology"},{"key":"2026100509323808100_cit39","doi-asserted-by":"publisher","first-page":"E1088","DOI":"10.1152\/ajpendo.00464.2009","article-title":"Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system","volume":"298","author":"Pe\u0301rez-Tilve","year":"2010","journal-title":"Am. J. Physiol.: Endocrinol. Metab."},{"key":"2026100509323808100_cit40","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/dom.70427","article-title":"GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models","volume":"28","author":"Baumer-Harrison","year":"2026","journal-title":"Diabetes, Obes. Metab."},{"key":"2026100509323808100_cit41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/dom.13222","article-title":"A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents","volume":"20","author":"Mietlicki-Baase","year":"2018","journal-title":"Diabetes, Obes. Metab."},{"key":"2026100509323808100_cit42","doi-asserted-by":"publisher","DOI":"10.1530\/joe-23-0226","article-title":"The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines","volume":"261","author":"Douros","year":"2024","journal-title":"J. Endocrinol."},{"key":"2026100509323808100_cit43","doi-asserted-by":"publisher","first-page":"102156","DOI":"10.1016\/j.xcrm.2025.102156","article-title":"Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R\/GIPR biased agonism yielding greater efficacy","volume":"6","author":"Rodriguez","year":"2025","journal-title":"Cell Rep. Med."},{"key":"2026100509323808100_cit44","doi-asserted-by":"publisher","first-page":"14970","DOI":"10.1021\/jacs.6b08323","article-title":"\u03b2-Arrestin-Biased Agonists of the GLP-1 Receptor from beta-Amino Acid Residue Incorporation into GLP-1 Analogues","volume":"138","author":"Hager","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"2026100509323808100_cit45","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1111\/dom.16660","article-title":"Evaluating biased agonism of glucagon-like peptide-1 (GLP-1) receptors to improve cellular bioenergetics: A systematic review","volume":"27","author":"Wong","year":"2025","journal-title":"Diabetes, Obes. Metab."},{"key":"2026100509323808100_cit46","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.molmet.2025.102124","article-title":"A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice","volume":"100","author":"Douros","year":"2025","journal-title":"Mol. Metab."},{"key":"2026100509323808100_cit47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bph.15497","article-title":"The therapeutic potential of GLP-1 receptor biased agonism","volume":"179","author":"Jones","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026100509323808100_cit48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Mu\u0308ller","year":"2019","journal-title":"Mol. Metab."},{"key":"2026100509323808100_cit49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12672-013-0163-9","article-title":"Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma","volume":"5","author":"Honors","year":"2014","journal-title":"Horm. Cancer"},{"key":"2026100509323808100_cit50","doi-asserted-by":"publisher","first-page":"R1190","DOI":"10.1152\/ajpregu.00163.2004","article-title":"Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R","volume":"287","author":"Grill","year":"2004","journal-title":"Am. J. Physiol.: Regul., Integr. Comp. Physiol."},{"key":"2026100509323808100_cit51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.physbeh.2015.10.031","article-title":"Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea","volume":"153","author":"De Jonghe","year":"2016","journal-title":"Physiol. Behav."},{"key":"2026100509323808100_cit52","doi-asserted-by":"publisher","first-page":"R1537","DOI":"10.1152\/ajpregu.1999.277.5.r1537","article-title":"A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia","volume":"277","author":"Rinaman","year":"1999","journal-title":"Am. J. Physiol."},{"key":"2026100509323808100_cit53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamaoncol.2023.5573","article-title":"GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight\/Obesity","volume":"10","author":"Wang","year":"2024","journal-title":"JAMA Oncol."},{"key":"2026100509323808100_cit54","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamaoncol.2025.2681","article-title":"GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity","volume":"11","author":"Dai","year":"2025","journal-title":"JAMA Oncol."},{"key":"2026100509323808100_cit55","doi-asserted-by":"publisher","first-page":"107401","DOI":"10.1016\/j.phrs.2024.107401","article-title":"Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials","volume":"208","author":"Figlioli","year":"2024","journal-title":"Pharmacol. Res."},{"key":"2026100509323808100_cit56","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Network Open"},{"key":"2026100509323808100_cit57","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3892\/or.2015.4476","article-title":"Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"2026100509323808100_cit58","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"2026100509323808100_cit59","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1210\/en.2011-1201","article-title":"Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells","volume":"152","author":"Koehler","year":"2011","journal-title":"Endocrinology"},{"key":"2026100509323808100_cit60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10549-011-1585-0","article-title":"The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells","volume":"132","author":"Ligumsky","year":"2012","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00590","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4988\/68399206\/mp6c00590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4988\/68399206\/mp6c00590.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:26Z","timestamp":1791208166000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/4988\/5422089\/A-Dicyanocobinamide-Conjugate-of-the-GLP-1R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,7]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00590","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}